Summary Three patients of histopathologically confirmed borderline-tuberculoid leprosy showing no acid-fast bacilli and with lesions confined to the face, 2 on the cheek and I on the fo rehead, were given multidrug therapy as recommended by
the WHO for paucibacillary cases. Within 3 months the lesions showed signs of upgrading (or reversal) reaction which was substantiated by histopathology. In I patient the fa cial nerve was affected leading to fa cial palsy. The lymphocyte transformation test did not show a significant rise. All 3 patients were given oral prednisolone for periods varying between 5 and 7 months, but the response was poor except in 1 patient in whom the fa cial palsy responded favourably. Injections of sodium antimony gluconate tried in I patient after stoppage of steroids did not control the reaction. After 18 months of regular fo llow-up during therapy, the cutaneous reaction in the patient with fa cial nerve involvement subsided leaving significant atrophy. However, in the other 2 patients the skin lesion persisted with clinical and histopathological evidence of upgrading reaction. The reasons for the unnatural persistence of reaction in these patients is not clear.
Reactions are an important clinical component of leprosy resulting from immunological changes in the patient. Alteration in cell-mediated immunity results in upgrading or downgrading reactions in borderline leprosy and antigen-antibody complexes are involved in reactions occurring in lepromatous leprosy. Being acute exacerbations these reactions can lead to severe tissue damage which in the nerves may lead to paralysis. Fortunately with the administration of anti-inflammatory drugs and corticosteroids reactions can be brought under control. This report describes 3 patients in whom the reaction persisted unusually up to 18 months and more despite proper therapy.
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A 48-year-old woman came to the clinic with a localized skin lesion on the fo rehead of 6 months' duration. On examination a well-defined, raised, erythematous, indurated, hypoaesthetic plaque on the fo rehead above the left eye extending to the root of the nose was seen. Hairs in the left eyebrow were sparse. There was no thickening of the nerves. Routine blood and urine tests were within normal limits. Histopathology confirmed the clinical diagnosis of borderline tuberbuloid (BT) leprosy. No acid-fast bacilli (AFB) were demonstrable. The Mitsuda reaction (with 0· 1 ml of armadillo-derived lepromin given intradermally) was positive and read 8 mm in diameter. The patient was put on paucibacillary multidrug therapy (PBMDT) as recommended by the WHO; 1 rifampicin 600 mg/month supervised and dapsone 100 mg/day. After 3 months of therapy the lesion became oedematous, angry looking and slightly tender. Nerves were uninvolved as before and there were no constitutional symptoms. A clinical diagnosis of Type I upgrading reaction was made and supported by histopathological examination. Lymphocyte transformation test (L TT) to sonicated My cobacterium leprae indicated a stimulation index (SI) of 1·8 (> 2 being significant).
In view of the locatiofi ofthe lesion and restriction ofleft upper eyelid movement, oral prednisolone 40 mg/day was given, later increased to 60 mg/day and continued for 12 weeks. There was no appreciable change except that oedema was slightly less and scaling had appeared indicating that the reaction had become subacute (Figure 1 ). To avoid the serious side-effects of steroid therapy the dose was tapered to 20 mg/day and stopped after 4 months as there was no fu rther change in the lesion. Following stoppage of steriods injections of sodium antimony gluconate 500 mg im daily were given in addition to PBMDT. After 8 weeks the injections were stopped as there was no significant improvement. At present, even after 18 months' treatment the patient has not come out of reaction but she has not worsened. Histopathology repeated now revealed oedema in the dermal granuloma and heavy lymphocytic infiltration in the periphery of the granuloma suggestive of upgrading reaction (Figure 2 ). 
Case 2
A 27-year-old woman who sought advice for a patch on the cheek of 8 months' duration was fo und to have a localized, raised, scaly, indurated red plaque with diminished sensations on the right cheek, 5 em in diameter (Figure 3 ). Local and regional cutaneous nerves were not thickened. Histopathology showed fe atures of BT leprosy with no AFB and the lepromin test read 8 mm. She was advised PBMDT. After 2t months the skin lesion started showing signs of reaction with increase in redness and swelling: a diagnosis of Type I upgrading reaction was made and confirmed on histopathology. LTT showed an SI of 1·8. Seeing no satisfactory response to nonsteroidal anti-inflammatory drugs, prednisolone was started as for Case I and given for a total of 7 months, but still the reaction did not show signs of regression and has persisted for the past 18 months. Histopathology repeated at this stage showed signs of upgrading reaction. An 18-year-old boy attended the clinic with a patch on the left cheek of 5 months' duration. Examination revealed an erythematous, indurated, hypo aesthetic plaque 6 cm in diameter occupying the centre of the left cheek. Nerves in the vicinity of the patch were not affected. Our clinical impression of leprosy was confirmed histopathologically which showed fe atures of BT. Lepromin read 5 mm. He was given PBMDT. After 2 months the lesion showed increasing redness, oedema and slight tenderness. There were signs of lef t sided fa cial palsy and no constitutional symptoms. The patient was immediately put on prednisolone 60 mg/day and aspirin 300 mg three times a day. Within 3 months, during which the steroids were monitored and brought to 20 mg/day, the facial palsy improved appreciably but only tenderness subsided in the skin lesion; the erythema and oedema persisted. Histopathology revealed fe atures of an upgrading reaction and no AFB. Steroids were gradually tapered and stopped after 2 more months of therapy. After 18 months the lesion started regressing and 2 months later it had subsided completely leaving a significant depression in the left cheek and mild-facial palsy (Figure 4 ). Antileprosy drugs were stopped and the patient was kept under surveillance.
Discussion
The majority of upgrading or reversal reactions usually occur within the first 6 months of therapy2 and seldom continue for more than a few months,3 the mean duration recorded in one study being 7·9 weeks.4 All 3 patients described in this report were unusual in the sense that the reactions persisted for a long period in the absence of provocative fa ctors like intercurrent infection, pregnancy and obvious mental or physical stress. They were regular in taking therapy and the diagnosis of upgrading reaction was confirmed on histopathology. Slit-skin smears had revealed no AFB.
The first 2 patients with skin involvement did not respond fa vourably to the drugs given to control the reaction including steroids and injections of sodium antimony gluconate in 1. Interestingly none of them worsened during the period of observation. The third patient who had both skin and nerve involvement ran a similar course. Here the neuritic component responded relatively earlier and better than the skin lesion, and the fa cial palsy had improved considerably with therapy. After 18 months the skin lesion subsided unlike the first 2 patients in whom the reaction persisted. This differential response of the skin and nerve may be incidental or may reflect the difference in antigenicity5 where the cytoplasmic antigen of M. /eprae is said to play a predominant role in reactions occurring in nerves and the whole cell antigen in the skin. The significant atrophy seen in the last patient after subsidence of the skin lesion indicates the considerable tissue damage caused when the reaction smoulders for a long time.
L TT done in 2 patients was not significantly raised. This too was unusual as L TT is supposed to be increased in reactional states.6 Although no explanation for this can be given at present it may represent an immunological observation in reactions that persist for a long time and can be confirmed when more patients with similar presentations are studied. The absence of constitutional symptoms and no rise in L TT also indicate that local fa ctors may be playing a significant role in such reactions.
Persistance de reaction chez la lepre paucibacillaire UMA SAXENA, V RAMESH, R S MISRA ET ASHOK MUKHERJEE Somma ire Trois patients avec cas limites de lepre confirmes par histopathologie, sans evidence de bacilles acido-resistants et avec lesions limitees au visage (deux sur Ie jumeau, une sur Ie front), ont ete mis so us un traitement it drogues multiples suivant les recommendations de la OMS pour des cas paucibacillaires. Dans une periode de trois mois, les lesions ont montre signes de 'reaction augmentee' (ou renversee) corrobores par des resultats d'histopathologie. Chez un des patients, Ie nerf fa cial a eti: affecte, produisant une paralyse facial. L'essai de transformation des lymphocytes n'a pas subi une hausse importante. Tous les trois patients ont pris de la prednisolone par voie orale, mais la reponse n'a pas ete bonne, sauf dans un cas, ou la paralyse fa cial a bien reagi . Des piqilres de gluconat de sodium et d'antimoine administrees chez un patient apn�s avoir arrete des steroides n'ont pas reussi it controler la reaction. Apres 18 mois sous observation reguliere pendant Ie trailement, la reaction cutanee chez Ie patient avec problemes du nerf facial a diminue, et a laisse un niveau d'alrophie considerable. Neanmoins, chez les autres deux patients, la lesion cutanee a persiste, avec evidence c1inique et d'histopathologie de reaction renversee. Les raisons pour cette persistance anormal de reaction chez ces patients ne sont pas evidentes.
Persistencia de reaccion inversa en casos de lepra paucibacilar UMA SAXENA, V RAMESH, R S MISRA y ASHOK MUKHERJEE Resumen Fueron sometidos a un tratamiento de drogas multiples tres pacientes con casos inciertos de lepra tuberculosa confirmados histopatol6gicamente, carentes de bacilos acidorresistentes, y con lesiones limitadas a la cara (dos en la mejilla, una en la frente), segun las recommendaciones de la OMS para casos paucibacilares. En un periodo de tres meses, las lesiones mostraron seiiales de 'reaccion aumentada' (0 inversa), que fueron corroboradas por resultados histopatologicos. En uno de los pacientes se via afectado el nervio facial, produciendo una panilisis facial. La prueba de transformacion de linfocitos no aumento de manera importante. Se administro prednisolona por via oral a los tres pacientes durante periodos entre cinco y siete meses, pero no respondieron bien, excepto en un caso, en el cual la panilisis facial si respondio de manera favorable. En un paciente, inyecciones de gluconato de sodio y antimonio administradas tras un cese de esteroides, no lograron controlar la reaccion. Tras 18 meses bajo observacion regular durante el tratamiento, la reaccion cutimea en el paciente con problemas de nervio facial disminuy6, dejando un nivel de atrofia considerable. Pero en los otros dos casos persistitio la lesion cutanea, con indicios clinicos e histopatologicos de reaccion inversa. Las razones de esta persistencia anormal de reaccion no estan claras.
